← Eichor
Condition: Renal Cell Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Renal Cell Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy
Phase 1 · 1 location(s) · University Hospital of Split · NCT06595329Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized C
Phase N/A · 1 location(s) · Mingzhao Xiao · NCT06088134Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Latera
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06572501Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · 35 location(s) · University College, London · NCT03288532Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
NA · 2 location(s) · Radboud University Medical Center · NCT07680556Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Hist
Phase 2 · 4 location(s) · Emory University · NCT05756569Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
Phase N/A · 1 location(s) · Loyola University · NCT05728957Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06940518The Cold Ischemia Robot-assisted Partial Nephrectomy
NA · 1 location(s) · Sun Yat-sen University · NCT07326280Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018CAIX PET/ CT Guided Radiation Therapy in CcRCC.
NA · 1 location(s) · Peking University First Hospital · NCT07540260Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biologica
Phase N/A · 5 location(s) · National Cancer Institute (NCI) · NCT01109394The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Phase N/A · 1 location(s) · VastBiome · NCT05037825Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Phase N/A · 1 location(s) · Palo Alto Veterans Institute for Research · NCT07303725Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Phase 2/Phase 3 · 4 location(s) · University of British Columbia · NCT06124976Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT04892849Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06868927Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy
Phase N/A · 1 location(s) · GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT06532422Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Phase 2 · 3 location(s) · University of Colorado, Denver · NCT05969496This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Tor
Phase 1 · 3 location(s) · Zumutor Biologics Inc. · NCT06451497Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05155033Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Phase 1 · 13 location(s) · DeuterOncology · NCT05752552Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Phase 1 · 5 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT05868174Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04473781Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metast
Phase 2 · 1 location(s) · Yale University · NCT04974671SABR for Renal Tumors
NA · 1 location(s) · University Health Network, Toronto · NCT03747133Imaging of Solid Tumors Using 18F-TRX
Phase 1 · 1 location(s) · Rahul Aggarwal · NCT06942104Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
Phase 2 · 2 location(s) · Jinling Hospital, China · NCT07611825Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT0689978968Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
NA · 1 location(s) · Peking University First Hospital · NCT06519760
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.